期刊文献+

雌二醇代谢产物对肝星状细胞增殖及TGF-β_1、CTGF表达的影响

The effects of estradiol metabolites on the proliferation and the production of TGF-β1 and CTGF of human hepatic stellate cells
下载PDF
导出
摘要 目的研究雌二醇(E2)代谢产物:2-羟雌二醇(2OHE)、2-甲氧雌二醇(2MeOE)、4-羟雌二醇(4OHE)对活化的人肝星状细胞(LX-2)增殖及对细胞内转化生长因子β1(TGF-β1)和结缔组织生长因子(CTGF)水平的影响。方法用不同浓度的E2、2OHE、4OHE、2MeOE处理LX-2细胞48 h,实验终点用MTT法检测LX-2增殖情况、RT-PCR方法检测TGF-β1、CTGF mRNA的水平及细胞免疫化学法检测TGF-β1、CTGF蛋白的水平。结果在10-9M^10-7M的药物浓度范围,E2及E2代谢产物干预组的LX-2细胞光密度值(optical density,OD)和细胞内TGF-β1、CTGF mRNA及蛋白水平均较空白对照组低,E2代谢产物干预组各项指标下降更为明显,尤以2MeOE组突出,差异具有显著性(P<0.05)。结论 E2及E2代谢产物均能抑制肝星状细胞的增殖、下调TGF-β1和CTGF蛋白浓度,并呈剂量效应关系;比较同一浓度的不同干预药物,E2代谢产物的作用均强于E2,其中2MeOE的生物活性最强。 [ Objective ] To evaluate the effects of estradiol (E2) metabolites: 2-hydroxyestradiol (2OHE), 4-hydroxyestradiol (4OHE) and 2-methoxyestradiol (2MeOE) on the proliferation and production of transforming growth factor-β,(TGF-β) and connective tissue growth faetor(CTGF) of activated human hepatic stellate cells(LX-2 cells). [ Methods ] LX-2 cells were incubated with different concentrations of E2, 2OHE, 4OHE and 2MeOE for 48 hours, at the end point, analyzing the proliferation of the cells by MTr assay, detecting the mRNA and protein levels of TGF-β1, CTGF through RT-PCR and cellular immunochemistry separately. [Results] Among the concentrations of 10^-9 M-10^-7 M, these parameters such as optical density, mRNA levels and the concentrations of TGF-β1 and CTGF of LX-2 from the groups treated with estradiol or its metabolites were lower than those from the control group, and the values of the groups treated with estradiol metabolites were lower than the group treated with estradiol, especially in the group treated with 2MeOE, these difference had statistics significance (P 〈0.05). [ Conclusions ] estradiol and its metabolites could inhibit the proliferation and production of transforming growth factor-β1 (TGF-β1) and connective tissue growth factor (CTGF) of hepatic stellate cells at a dose dependent manner, estradiol metabolites had stronger effect than E2 and 2MeOE had the highest activity.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2012年第34期26-30,共5页 China Journal of Modern Medicine
关键词 雌二醇代谢产物 雌二醇 肝星状细胞 TGF-β1 CTGF estradiol metabolites estradiol hepatic stellate cell TGF-β1 CTGF
  • 相关文献

参考文献11

  • 1GR ESSNER AM. -EISKIRCHEN R. BREITKOPF K, -t al.Roles of TGF-beta in hepatic fibrosis[J]. Frontiers in bioscience, 2002, 7: 793-807.
  • 2VOGELMANN R, RUF D, WAGNER M, et al. Effects of fibro- genic mediators on the development of pmmreatic fibrosis in a TGF-betal transgenic mouse model [J]. Am J Physiol Gastrointest liver Physiol, 2001, 280(1): 164-172.
  • 3HOLMES A, ABRAHAM DJ, SA S, et al. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling [J]. The Journal of Biological Chemistry, 2001, 276(14): 10594-10601.
  • 4谢建萍,全俊,周建亮,刘菲,黄柳云,谭德明,潘一峰.β-雌二醇及其纳米粒对肝星状细胞增殖和活化的影响[J].中华肝脏病杂志,2007,15(10):785-786. 被引量:1
  • 5谢建萍,谭德明,汪玲,周建亮,刘菲,黄柳云,潘一峰.雌二醇纳米粒对大鼠免疫性肝纤维化模型的作用[J].中华传染病杂志,2008,26(1):9-13. 被引量:1
  • 6刘菲,谢建萍,黄柳云,等.B-雌二醇及其纳米粒对肝星状细胞TGF-B1和CTGF的影响[J].胃肠病学和肝学病杂志,2007,16(6):56I-565.
  • 7KARAS RH, HODGIN JB, KWOUN M, et al. Estrogen inhibits the vascular injury response in estrogen receptor beta -deficient female mice[J]. PNAS, 1999, 96(26): 15133-15136.
  • 8LAVALLEE TM, ZHAN XH, JOHNSON MS, et al. 2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway [J]. Cancer Res, 2003, 63(2): 468-475.
  • 9TZORTZAKI EG, ANTONIOU KM, ZERVOU MI, et al. Effects of antifibrotic agents on TGF-13 1, CTGF and IFN-'y expression in patients with idiopathic pulmonary fibrosis [J]. Respiratory Medicine, 2007, 10(8): 1821-1829.
  • 10I刘清华,李定国,黄新,等.雌激素代谢产物介导雌激素抗肝纤维化作用[J].胃肠病学和肝学病杂志,2003,12(6):538-543.

二级参考文献14

  • 1谢建萍,谭德明,肖平,潘一峰,周建亮.β-雌二醇聚氰基丙烯酸正丁酯纳米粒制备工艺的研究[J].中国医学工程,2006,14(5):452-455. 被引量:7
  • 2谢建萍,周建亮,刘菲,潘一峰,全俊,谭德明.雌二醇聚氰基丙烯酸正丁酯纳米粒肝脏靶向性研究[J].中国医学工程,2007,15(4):312-315. 被引量:5
  • 3Shiga A, Shirota K. Ikeda T, ct al. Morphological and immunohistochemical studies on porcinc scrum-induced rat liver fibrosis. J Vet Med Sci, 1997, 59:159-167.
  • 4Yoshikawa T, Tsutsumi Y. Nakagawa S. Development of nanomedicine using intracellular DDS. Nippon Rinsho, 2006. 64:247-252.
  • 5Itagaki T. Shimizu I, Cheng X. ct al. Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidativc stress induced activation of cultured rat hepatic stellate cells. Gut, 2005, 54: 1782- 1789.
  • 6Tsuchiya Y, Nakajima M, Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett, 2005 ,227:115-124.
  • 7Kayser O, Lemke A, Hernandez-Trejo N.The impact of nanobiotechnology on the development of new drug delivery systems, Curr Pharm Biotechnol, 2005, 6: 3-5.
  • 8Liu C J, Jeng YM, Chen PJ, et al. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C. Antivir Ther, 2005, 10: 405-415.
  • 9Shiga A, Shirota K, Ikeda T, et al. Morphological and immunohistochemical studies on porcine serum-induced rat liver fibrosis. J Vet Med Sci, 1997, 59:159-167.
  • 10Wang W, Zhu GJ, Zu SY. Effects of 17beta-estradiol and phytoestrogen alpha-zearalanol on tissue factor in plasma of ovariectomized rats and HUVECs. Chin J Physiol, 2004, 47: 67-72.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部